{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T19:59:30Z","timestamp":1786564770089,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10554-021-02430-w","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T12:25:43Z","timestamp":1634300743000},"page":"643-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"38","author":[{"given":"Yanwei","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhe","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"9862","key":"2430_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381(9862):242\u2013255","journal-title":"Lancet"},{"issue":"4","key":"2430_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0735-1097(02)02020-X","volume":"40","author":"MJ Eriksson","year":"2002","unstructured":"Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle D et al (2002) Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 40(4):837\u2013838","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2430_CR3","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.amjcard.2013.02.040","volume":"111","author":"KW Klarich","year":"2013","unstructured":"Klarich KW, Attenhofer Jost CH, Binder J, Connolly HM, Scott CG, Freeman WK et al (2013) Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol 111(12):1784\u20131791","journal-title":"Am J Cardiol"},{"issue":"5","key":"2430_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1536\/ihj.17.611","volume":"17","author":"T Sakamoto","year":"1976","unstructured":"Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y (1976) Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 17(5):611\u2013629","journal-title":"Jpn Heart J"},{"issue":"2","key":"2430_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/oxfordjournals.eurheartj.a060887","volume":"16","author":"E Moro","year":"1995","unstructured":"Moro E, D\u2019Angelo G, Nicolosi G, Mimo R, Zanuttini D (1995) Long-term evaluation of patients with apical hypertrophic cardiomyopathy. Correlation between quantitative echocardiographic assessment ofapical hypertrophy and clinical-electrocardiographic findings. Eur Heart J 16(2):210\u2013217","journal-title":"Eur Heart J"},{"key":"2430_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.62.728.567","author":"T Sakamoto","year":"1986","unstructured":"Sakamoto T, Amano K, Hada Y, Tei C, Takenaka K, Hasegawa I et al (1986) Asymmetric apical hypertrophy ten years experience. Postgrad Med J. https:\/\/doi.org\/10.1136\/pgmj.62.728.567","journal-title":"Postgrad Med J"},{"issue":"11","key":"2430_CR7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.amjcard.2011.07.024","volume":"108","author":"J Moon","year":"2011","unstructured":"Moon J, Shim CY, Ha JW, Cho IJ, Kang MK, Yang WI et al (2011) Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Am J Cardiol 108(11):1614\u20131619","journal-title":"Am J Cardiol"},{"issue":"12","key":"2430_CR8","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"2430_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM199703133361107","volume":"336","author":"P Spirito","year":"1997","unstructured":"Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336(11):775\u2013785","journal-title":"N Engl J Med"},{"issue":"15","key":"2430_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","volume":"118","author":"MS Maron","year":"2008","unstructured":"Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS et al (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118(15):1541\u20131549","journal-title":"Circulation"},{"issue":"15","key":"2430_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/heartjnl-2015-309121","volume":"102","author":"H Kim","year":"2016","unstructured":"Kim H, Park JH, Won KB, Yoon HJ, Park HS, Cho YK et al (2016) Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy. Heart 102(15):1215\u20131220","journal-title":"Heart"},{"issue":"21","key":"2430_CR12","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.119.040271","volume":"140","author":"A Weissler-Snir","year":"2019","unstructured":"Weissler-Snir A, Allan K, Cunningham K, Connelly KA, Lee DS, Spears DA et al (2019) Hypertrophic cardiomyopathy-related sudden cardiac death in young people in Ontario. Circulation 140(21):1706\u20131716","journal-title":"Circulation"},{"issue":"1","key":"2430_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jacc.2004.09.054","volume":"45","author":"AM Pritchett","year":"2005","unstructured":"Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfield MM (2005) Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 45(1):87\u201392","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2430_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/01.CIR.92.4.835","volume":"92","author":"EJ Benjamin","year":"1995","unstructured":"Benjamin EJ, D\u2019Agostino RB, Belanger AJ, Wolf PA, Levy D (1995) Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 92(4):835\u2013841","journal-title":"Circulation"},{"issue":"5","key":"2430_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0002-9149(00)01019-5","volume":"86","author":"A Rossi","year":"2000","unstructured":"Rossi A, Tomaino M, Golia G, Santini F, Pentiricci S, Marino P, Zardini P (2000) Usefulness of left atrial size in predicting postoperative symptomatic improvement in patients with aortic stenosis. Am J Cardiol 86(5):567\u2013570","journal-title":"Am J Cardiol"},{"issue":"17","key":"2430_CR16","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1161\/01.CIR.0000066318.21784.43","volume":"107","author":"JE Moller","year":"2003","unstructured":"Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS et al (2003) Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 107(17):2207\u20132212","journal-title":"Circulation"},{"issue":"12","key":"2430_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.echo.2009.09.016","volume":"22","author":"WI Yang","year":"2009","unstructured":"Yang WI, Shim CY, Kim YJ, Kim SA, Rhee SJ, Choi EY et al (2009) Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 22(12):1338\u20131343","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"2430_CR18","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","volume":"42","author":"L Monserrat","year":"2003","unstructured":"Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ (2003) Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Am Coll Cardiol 42(5):873\u2013879","journal-title":"J Am Coll Cardiol"},{"issue":"30","key":"2430_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O'Mahony","year":"2014","unstructured":"O\u2019Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C et al (2014) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 35(30):2010\u20132020","journal-title":"Eur Heart J"},{"issue":"11","key":"2430_CR20","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.amjcard.2010.01.020","volume":"105","author":"R Fattori","year":"2010","unstructured":"Fattori R, Biagini E, Lorenzini M, Buttazzi K, Lovato L, Rapezzi C (2010) Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 105(11):1592\u20131596","journal-title":"Am J Cardiol"},{"issue":"6","key":"2430_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ehjci\/jex323","volume":"19","author":"G Quarta","year":"2018","unstructured":"Quarta G, Aquaro GD, Pedrotti P, Pontone G, Dellegrottaglie S, Iacovoni A et al (2018) Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context. Eur Heart J Cardiovasc Imaging 19(6):601\u2013610","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2430_CR22","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ijcard.2016.07.154","volume":"222","author":"MF Jan","year":"2016","unstructured":"Jan MF, Todaro MC, Oreto L, Tajik AJ (2016) Apical hypertrophic cardiomyopathy: present status. Int J Cardiol 222:745\u2013759","journal-title":"Int J Cardiol"},{"issue":"6","key":"2430_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130(6):484\u2013495","journal-title":"Circulation"},{"issue":"12","key":"2430_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/ehjci\/jeaa246","volume":"21","author":"K Yang","year":"2020","unstructured":"Yang K, Song YY, Chen XY, Wang JX, Li L, Yin G et al (2020) Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: prevalence, cardiac magnetic resonance characteristics, and prognosis. Eur Heart J Cardiovasc Imaging 21(12):1341\u20131350","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-021-02430-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T08:18:49Z","timestamp":1647418729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-021-02430-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2430"],"URL":"https:\/\/doi.org\/10.1007\/s10554-021-02430-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-576943\/v1","asserted-by":"object"}]},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"30 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the institutional review boards and all subjects provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}